^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    HER-2/neu peptide vaccine

    i
    Associations
    News
    Trials
    Company:
    National Cancer Institute - Bethesda
    Drug class:
    HER2 inhibitor
    Related drugs:
    Associations
    News
    Trials